Loading of MHC Class I and II Presentation Pathways by Exogenous Antigens: A Quantitative In Vivo Comparison
暂无分享,去创建一个
[1] K. Schwarz,et al. Nonmethylated CG Motifs Packaged into Virus-Like Particles Induce Protective Cytotoxic T Cell Responses in the Absence of Systemic Side Effects , 2004, The Journal of Immunology.
[2] C. Harding,et al. Processing of Exogenous Antigens for Presentation by Class I MHC Molecules Involves Post-Golgi Peptide Exchange Influenced by Peptide-MHC Complex Stability and Acidic pH , 2003, The Journal of Immunology.
[3] Peter J. S. Hutzler,et al. Tumor-Derived Heat Shock Protein 70 Peptide Complexes Are Cross-Presented by Human Dendritic Cells1 , 2002, The Journal of Immunology.
[4] G. Lipowsky,et al. Regulation of IgG antibody responses by epitope density and CD21‐mediated costimulation , 2002, European journal of immunology.
[5] R. Zinkernagel. On cross‐priming of MHC class I‐specific CTL: rule or exception? , 2002, European journal of immunology.
[6] U. Koszinowski,et al. The Murine Cytomegalovirus Immunomodulatory Gene m152 Prevents Recognition of Infected Cells by M45-Specific CTL But Does Not Alter the Immunodominance of the M45-Specific CD8 T Cell Response In Vivo1 , 2002, The Journal of Immunology.
[7] J. Yewdell,et al. Inhibitory Effects of Cytomegalovirus Proteins US2 and US11 Point to Contributions from Direct Priming and Cross-Priming in Induction of Vaccinia Virus-Specific CD8+ T Cells , 2002, The Journal of Immunology.
[8] A. Jegerlehner,et al. Critical Role for Activation of Antigen-Presenting Cells in Priming of Cytotoxic T Cell Responses After Vaccination with Virus-Like Particles1 , 2002, The Journal of Immunology.
[9] Scott N. Mueller,et al. Rapid Cytotoxic T Lymphocyte Activation Occurs in the Draining Lymph Nodes After Cutaneous Herpes Simplex Virus Infection as a Result of Early Antigen Presentation and Not the Presence of Virus , 2002, The Journal of experimental medicine.
[10] F. Lechner,et al. Cross‐presentation of virus‐like particles by skin‐derived CD8– dendritic cells: a dispensable role for TAP , 2002, European journal of immunology.
[11] J. Yewdell,et al. Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo , 2002, Nature Immunology.
[12] Antonio Lanzavecchia,et al. Regulation of T Cell Immunity by Dendritic Cells , 2001, Cell.
[13] S. Akira,et al. Toll-like receptors: critical proteins linking innate and acquired immunity , 2001, Nature Immunology.
[14] P. Pumpens,et al. HBV Core Particles as a Carrier for B Cell/T Cell Epitopes , 2001, Intervirology.
[15] J. Yewdell,et al. Cutting Edge: Recombinant Adenoviruses Induce CD8 T Cell Responses to an Inserted Protein Whose Expression Is Limited to Nonimmune Cells , 2001, The Journal of Immunology.
[16] J. Lifson,et al. MHC-I–restricted presentation of HIV-1 virion antigens without viral replication , 2001, Nature Medicine.
[17] R. Steinman,et al. Brief Definitive Report Dendritic Cells Cross-present Latency Gene Products from Epstein-barr Virus–transformed B Cells and Expand Tumor-reactive Cd8 Ϩ Killer T Cells , 2022 .
[18] M. Bevan,et al. Cd8+ but Not Cd8− Dendritic Cells Cross-Prime Cytotoxic T Cells in Vivo , 2000, The Journal of experimental medicine.
[19] P. Loetscher,et al. Cxc Chemokine Receptor 5 Expression Defines Follicular Homing T Cells with B Cell Helper Function , 2000, The Journal of experimental medicine.
[20] H. Rammensee,et al. Cross-Presentation of Glycoprotein 96–Associated Antigens on Major Histocompatibility Complex Class I Molecules Requires Receptor-Mediated Endocytosis , 2000, The Journal of experimental medicine.
[21] Jonathan W. Yewdell,et al. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes , 2000, Nature.
[22] N. Shastri,et al. Bacterial Proteins Can Be Processed by Macrophages in a Transporter Associated with Antigen Processing-Independent, Cysteine Protease-Dependent Manner for Presentation by MHC Class I Molecules1 , 2000, The Journal of Immunology.
[23] J. Yewdell,et al. Generating MHC class I ligands from viral gene products , 1999, Immunological reviews.
[24] J. Neefjes,et al. Recycling MHC class I molecules and endosomal peptide loading. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[25] M. Albert,et al. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs , 1998, Nature.
[26] R. Zinkernagel,et al. Virus‐specific major MHC class II‐restricted TCR‐transgenic mice: effects on humoral and cellular immune responses after viral infection , 1998, European journal of immunology.
[27] A. Diehl,et al. TAP peptide transporter-independent presentation of heat-killed Sendai virus antigen on MHC class I molecules by splenic antigen-presenting cells. , 1997, Journal of immunology.
[28] F. Marincola,et al. Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[29] Hans Hengartner,et al. Antigen localisation regulates immune responses in a dose‐ and time‐dependent fashion: a geographical view of immune reactivity , 1997, Immunological reviews.
[30] J. Pfeifer,et al. Major histocompatibility complex class I presentation of ovalbumin peptide 257–264 from exogenous sources: protein context influences the degree of TAP‐independent presentation , 1996, European journal of immunology.
[31] D. Pardoll,et al. In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter. , 1996, Immunity.
[32] H. Rammensee,et al. Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96 , 1995, The Journal of experimental medicine.
[33] S. Tonegawa,et al. TAP1‐independent loading of class I molecules by exogenous viral proteins , 1995, European journal of immunology.
[34] J. Reimann,et al. Hepatitis B virus small surface antigen particles are processed in a novel endosomal pathway for major histocompatibility complex class I‐restricted epitope presentation , 1995, European journal of immunology.
[35] M. Kovacsovics-Bankowski,et al. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules , 1995, Science.
[36] R. Zinkernagel,et al. Induction of protective cytotoxic T cells with viral proteins , 1994, European journal of immunology.
[37] E. Jaffee,et al. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. , 1994, Science.
[38] Hans Hengartner,et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice , 1994, Nature.
[39] R. Zinkernagel,et al. Immunogenicity of a viral model vaccine after different inactivation procedures , 1994, Medical Microbiology and Immunology.
[40] T. Kündig,et al. In vivo versus in vitro assays for assessment of T- and B- cell function. , 1994, Current opinion in immunology.
[41] J. Reimann,et al. Immunization with soluble hepatitis B virus surface protein elicits murine H-2 class I-restricted CD8+ cytotoxic T lymphocyte responses in vivo. , 1994, Journal of immunology.
[42] K. Rock,et al. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[43] J. Pfeifer,et al. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells , 1993, Nature.
[44] R M Zinkernagel,et al. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. , 1991, Journal of virological methods.
[45] H. Pircher,et al. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen , 1989, Nature.
[46] M. Gething,et al. Antigen Presentation Pathways to Class I and Class II MHC‐Restricted T Lymphocytes , 1987, Immunological reviews.
[47] R. Zinkernagel,et al. Effects of cyclosporin A on humoral immune response and resistance against vesicular stomatitis virus in mice , 1986, Journal of virology.
[48] J. Schulman,et al. Cellular immune responses of mice to influenza virus vaccines. , 1980, Journal of immunology.
[49] J. Oliver,et al. Topographical distribution of coated pits , 1980, Nature.
[50] T. Braciale,et al. Role of viral infectivity in the induction of influenza virus-specific cytotoxic T cells , 1978, The Journal of experimental medicine.
[51] M. Bevan,et al. Induction of H-2-restricted cytotoxic T cells: in vivo induction has the appearance of being unrestricted. , 1977, Cellular immunology.
[52] M. Bevan,et al. Minor H antigens introduced on H-2 different stimulating cells cross-react at the cytotoxic T cell level during in vivo priming. , 1976, Journal of immunology.
[53] R. Germain,et al. The dynamics of T cell receptor signaling: complex orchestration and the key roles of tempo and cooperation. , 1999, Annual review of immunology.
[54] R. Andino,et al. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen , 1999, Nature.
[55] R. Zinkernagel,et al. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. , 1996, Annual review of immunology.
[56] H. Ploegh,et al. Generation, translocation, and presentation of MHC class I-restricted peptides. , 1995, Annual review of biochemistry.
[57] M. Battegay. [Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24 well plates] , 1993, ALTEX.
[58] M. Bevan,et al. Class I MHC-restricted cytotoxic responses to soluble protein antigen. , 1989, Cold Spring Harbor symposia on quantitative biology.